Journey Medical Corp Capital Reinvestment Ratio
Journey Medical Corp capital reinvestment ratio. Journey Medical Corp (DERM) has a Capital Reinvestment Ratio of 22.62x as of March 2022, meaning it reinvests 23% of its operating cash flow ($884.00K) in capital expenditures ($20.00 Million). Check Journey Medical Corp (DERM) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Journey Medical Corp (2019–2023)
Capital reinvestment ratio of Journey Medical Corp from 2019 to 2023. This chart tracks Journey Medical Corp's Capital Reinvestment Ratio across 3 annual periods. Also explore how fast is Journey Medical Corp growing its equity to track the company's year-over-year net asset growth rate.
Journey Medical Corp Capital Reinvestment Ratio by Year (2019–2023)
Journey Medical Corp capital reinvestment ratio by year from 2019 to 2023. For the full cash flow conversion analysis, see DERM operating cash flow.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.95x | $5.24 Million | $5.00 Million | ▲ +308.1% |
| 2020 | 0.23x | $5.13 Million | $1.20 Million | ▼ -12.1% |
| 2019 | 0.27x | $9.02 Million | $2.40 Million | — |